 HERTFORDSHIRE, England PITTSBURGH NEW YORK--BUSINESS WIRE--Mylan N.V. NASDAQ: MYL and Pfizer Inc. NYSE: PFE today announced that the U.S. Federal Trade Commission the FTC accepted a proposed consent order, which concludes the FTCs review of the proposed combination of Mylan and Pfizers Upjohn Business. The parties have now obtained all required antitrust clearances for the proposed transaction. The combination will be effected through a Reverse Morris Trust transaction, pursuant 